No Longer Accepting Cases

Darvon (generic: propoxyphene) is a synthetic opioid pain reliever used in the treatment of mild to moderate pain. However, recent studies suggest that the use of the medication may be related to sever, life-threatening Darvon side effects.

Darvon Overview

Darvon was a popular pain medication since Xanodyne Pharmaceuticals Inc. introduced it back in 1957. For more than 50 years, Darvon helped treat those suffering from chronic pain. However, recent studies suggest that the use of Darvon may be linked to fatal tendencies of overdose.

On January 30, 2009, an advisory committee of the U.S. Food and Drug Administration (FDA) acknowledged the potentially fatal side effects associated with the use of propoxyphene, the active ingredient in Darvon, in a press release. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm234350.htm In response to the committees information, the Health Research Group petitioned for the FDA to ban Darvon due to the confirmed link between propoxyphene and over 10,000 confirmed deaths since the 1980’s. As a result, Darvon was recalled and prompted the end of more than 50 years of distribution.

Side Effects of Darvon

Darvon side effects commonly reported include nausea, vomiting, constipation, lightheadedness, and dizziness. However, taking more than the recommended dose can cause severe and even fatal complications.

Meet Your Attorney

Collen A. Clark

Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.

“Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”

To contact Collen, please fill out the contact form below:

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 879-3040.
  • This field is for validation purposes and should be left unchanged.